ARCHIVES

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

This article is from The Cancer Letter archive.

Vol. 36 No. 30 | August 6, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

In Brief: Women’s Health Group Asks Magazines To Stop Accepting Tobacco Advertising

June 5, 1998

Step By Step: New Tenure Track, Appointments Process

August 5, 1994

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001